Latest article
Cognitive dysfunction impacts instructional efforts in sufferers with diabetes
July 06, 2021
Watch for 1 minute
ADD SUBJECT TO EMAIL ALERTS
Receive an email when new...
Novo Nordisk presents trial outcomes of Xultophy for sort 2 diabetes
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...